Technical Analysis for PVCT - Provectus Pharma

Grade Last Price % Change Price Change
grade A 0.066 10.37% 0.0062
PVCT closed up 10.37 percent on Friday, August 23, 2019, on 44 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical PVCT trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Crossed Above 50 DMA Bullish 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Up 3 Days in a Row Strength 0.00%
200 DMA Support Bullish 10.37%
Calm After Storm Range Contraction 10.37%
Narrow Range Bar Range Contraction 10.37%
NR7 Range Contraction 10.37%
Lower Bollinger Band Walk Weakness 10.37%
Stochastic Reached Oversold Weakness 10.37%

Older signals for PVCT ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Provectus Biopharmaceuticals, Inc. is a development-stage biopharmaceutical company. The Company is engaged in developing pharmaceuticals for oncology and dermatology indications. The Company is focused on developing its prescription drug candidates, PV-10 and PH-10. It is developing PV-10 for treatment of several life threatening cancers, including metastatic melanoma, liver cancer and breast cancer. It is developing PH-10 to provide minimally invasive treatment of chronic severe skin afflictions, such as psoriasis and atopic dermatitis, a type of eczema. In addition to clinical trials, patients enrolled in the expanded access or compassionate use program for PV-10 are also receiving PV-10 treatments for cutaneous and subcutaneous cancer indications. The Company also focuses on over-the-counter (OTC) products and various other non-core technologies. PV-10 is a sterile injectable form of rose bengal disodium (Rose Bengal), for direct injection into tumors.
RTT Pharmaceuticals Biopharmaceutical Chemical Compounds Organic Compounds Cancers Autoimmune Diseases Breast Cancer Ophthalmology Psoriasis Atopic Dermatitis Tumors Chloroarenes Dermatitis Eczema Liver Cancer Metastatic Melanoma Phenols Aromatic Compounds
Is PVCT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 1 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 0.0775
52 Week Low 0.0111
Average Volume 318,632
200-Day Moving Average 0.059
50-Day Moving Average 0.0652
20-Day Moving Average 0.0663
10-Day Moving Average 0.0634
Average True Range 0.0064
ADX 37.49
+DI 13.6574
-DI 23.0324
Chandelier Exit (Long, 3 ATRs ) 0.0548
Chandelier Exit (Short, 3 ATRs ) 0.0742
Upper Bollinger Band 0.0746
Lower Bollinger Band 0.058
Percent B (%b) 0.48
BandWidth 25.037707
MACD Line -0.0012
MACD Signal Line -0.0004
MACD Histogram -0.0008
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0785
Resistance 3 (R3) 0.0776 0.0725 0.0764
Resistance 2 (R2) 0.0725 0.0694 0.0730 0.0757
Resistance 1 (R1) 0.0693 0.0674 0.0709 0.0702 0.0750
Pivot Point 0.0642 0.0642 0.0651 0.0647 0.0642
Support 1 (S1) 0.0610 0.0611 0.0626 0.0619 0.0570
Support 2 (S2) 0.0559 0.0591 0.0564 0.0563
Support 3 (S3) 0.0527 0.0559 0.0556
Support 4 (S4) 0.0536